CN
230-135-2
应用筛选条件
关键词:'230-135-2'
显示 1-30 共 105 条结果 关于 "230-135-2" 范围 技术文档
Product Information - F3542
Animal Cell Culture Vol 1. Alan R. Liss, Inc., New York, NY. pp. 215-230.
11. Yong, V. W. et al. (1988). Dev. Neuroscience 10:222-230.
20. Ruoslahti, E. and Pierschbacher, M. (1987). Science 238:491-497
Understanding the Effect of Discreet PEG Linkers on ADC Structure and Binding
.1 211 80 500 94 299 132
PEG8 4.0 200 84 433 108 358 111
PEG12 3.9 230 74 572 82 361 110
PEG24 4.0 257 66 612 77 293 135
LC-SMCC 2.7 154 109 374
Product Information Sheet - S1629
).
5. Fowler, L.R., and Rammler, D.H., Biochemistry,
3(2), 230-237 (1964).
6. Olson, J.J., and Chu, F.S., J. Agric. Food Chem.,
41(2), 250-255 (1993).
7. Yamamoto, S. et al., Biosci. Biotech.
Specification Sheet: NovAseptic® Mixer Drive Unit, GMP ATEX
Voltage 230/400 V ~ 50 Hz
Number of Poles 2
Degree of Protection IP 65
Insulating Class CLF
Ventilation IC411 (TEFC)
Variable Speed Duty Quadratic Torque 5–50Hz
Thermostat 2 (PTC 110
Spare parts for Mobius® FlexReady Solution with Smart Flexware® Assemblies For Chromatography and TFF
144
2
129
131
132
133
134
135
149
78
134
140
145 152
144
141
139
142
129
135
133
GenElute-E Single SpinTissue DNA 96 Kit
260/230 ratios
appear to be
"too low."
In some cases, the 260/230 ratios may
be below the recommended range.
Downstream assays have not been shown to
be compromised by lower 260/230 ratios
User Manual - EC396
260/230 ratios
appear to be
"too low."
In some cases, the 260/230 ratios may
be below the recommended range.
Downstream assays have not been shown to
be compromised by lower 260/230 ratios
Data Sheet - T152
Sato, N., et al., JNCL, 78, 1113 (1986).
9. Sugarman, B., et al., Science, 230, 943 (1985).
10. Shalaby, M., et al., J. Immunol., 135, 2060 (1985).
11. Bertolini, D., Nature, 319, 516 (1986).
12. Dinarello
Data Sheet - T6674
Cancer Inst., 76, 1113
(1986).
9. Sugarman, B.J., et al., Science, 230, 943 (1985).
10. Shalaby, M., et al., J. Immunol., 135, 2060 (1985).
11. Bertolini, D R., Nature, 319, 516 (1986).
12. Dinarello
Data Sheet - T0157
N., et al., JNCL, 78, 1113 (1986).
9. Sugarman, B., et al., Science, 230, 943 (1985).
10. Shalaby, M., et al., J. Immunol., 135, 2060 (1985).
11. Bertolini, D., Nature, 319, 516 (1986).
12. Dinarello
Product Information Sheet - I1149
M.D. et al., J. Biol. Chem., 252, 5900,
1977.
26. Kirtley, M.E. and Rudney, H., Biochem., 6, 230,
1967.
27. Schulz, H. and Staack, H., Methods Enzymol., 71,
398, 1981.
Product Information Sheet - I6125
M.D. et al., J. Biol. Chem., 252, 5900,
1977.
26. Kirtley, M.E. and Rudney, H., Biochem., 6, 230,
1967.
27. Schulz, H. and Staack, H., Methods Enzymol., 71,
398, 1981.
Data Sheet - I5286
panspecific hemopoietin of
activated T lymphocytes (interleukin-3). Annu. Rev.
Immunol., 4, 205-230 (1986).
7. Davis G.E. et al., Control of vascular tube
morphogenesis and maturation in 3D extracellular
Data Sheet - T0813
Sato, N. et al., JNCL, 78, 1113 (1986).
9. Sugarman, B. et al., Science, 230, 943 (1985).
10. Shalaby, M. et al., J. Immunol., 135, 2060 (1985).
11. Bertolini, D., Nature, 319, 516 (1986).
12. Dinarello
Product Information Sheet - T7254
(I50=230 µM).
37
TLCK also inhibited human complement C6 (4 x 10-7M) in the range of 1O-2-1O-3M38, dog urinary kallikrein
(Ki=6.2 x 10
-3M)39, human enterokinase40, and boar acrosin (at 2 µM).41
Data Sheet - T0938
, et al., JNCL, 78, 1113 (1986).
9. Sugarman, B.J., et al., Science, 230, 943 (1985).
10. Shalaby, M.R., et al., J. Immunol., 135, 2060
(1985).
11. Bertolini, D.R., Nature, 319, 516 (1986).
12
XP725 Antibody Number-Lot Number 071M4826
271 272
3.3 201 202 203 204 225 226 227 228 249 250 251 252 273 274 275 276
3.4 205 206 207 208 229 230 231 232 253 254 255 256 277 278 279 280
3.5 209 210 211 212 233 234
JULABO Catalog 2011 en
12 mm 13 x 15 / 16 6.5 III (FL) 230/50-60/16 50 x 58 x 89 88 9 312 681 F81-HL
0.4-0.7 0.2-0.4 22-26 M16x1 8 / 12 mm 13 x 15 / 16 8 III (FL) 230/50/14 55
Product Information Sheet - T9033
Chemical Abstracts Registry data, American
Chemical Society.
2. Sigma Quality Control Data
3. Jager, A.K. et al., J. Chromatogr., 634, 135 (1993).
4. Christensen, S.B., and Schaumburg, K., J. Org.
Product Information Sheet - MAK219
µL.
2
Sample Preparation
Proteins in samples may impact background levels. To
remove proteins from samples, deproteinize using a
10 kDa MWCO spin filter.
Add 80–135 µL of the samples
Katalog OHAUS
0,5 g 340 x 230 mm 80251093 276
TR3RS-M 3 kg 1 g 340 x 230 mm 80251156 324
TR6RS-EU2 6 kg 1 g 340 x 230 mm 80251094 276
TR6RS-M 6 kg 2 g 340 x 230 mm 80251157 324
TR15RS-EU2 15 kg
App Note: Scalability Studies for Millistak+® HC and Millistak+® HC Pro Micro 20 Devices
internal diameter
(i.d.) at three different flow rates, as shown in Table 2
below. In all cases, the feed tubing length was 230 cm;
this tubing length was chosen to represent a worst-case
tubing length
Katalog neoLab
84 mm Ø 182 mm 230 x 116 x 116 mm 50 pcs./pack
2-2804 1000 ml 94 x 94 mm 104 mm Ø 225 mm 300 x 135 x 135 mm
Intracellular signal transduction pathways -MILLIPLEX®MAP Cell Signaling Phospho/Total 2-Plex assays
pathways simultaneously. HeLa:TNFα+CalA
(Cat. No. 47-230) and HepG2:Insulin (Cat. No. 47-227)
were used as stimulated cell lysates to compare the
2-plex assay results with those of a customized 16-plex
Brochure: Ascentis® Express Fused-Core® HPLC and UHPLC Columns
75% B in 2 min; held for
2 minutes
Flow Rate: 1.0 mL/min
Pressure: 2770 psi (191 bar)
Sample: Dissolved in 20:80 water:methanol
Injection: 1.0 µL
Detector: UV, 230 nm
0 1 2
BRAND Katalog EN
76 8800 01
2 C -5 / 300 1 390 76 8800 02
3 C -5 / 400 1 415 76 8800 03
5 C -38 / 50 1 230 108 8800 04
6 C -80 /
Virus Retention Performance of Viresolve®Pro Devices under a Range of Processing Conditions
concentration from 2-25 g/L. No differences in
retention were observed with increased filter fouling to
90% plugged (V90).
Study 1: mAb 02.1 at 20 g/L was diluted in buffer
[10 mM Citrate, 135 mM NaCl pH5
Biologics 32.3: NF-kB Activation: A Link Between Chronic Inflammation and Cancer
13Calbiochem • Biologics 32.3
Anti-mTOR/FRAP (Ab-2) Mouse mAb (22C2)
Liquid, Protein G purified. Immunogen used was a
synthetic peptide corresponding to amino acids 230-240
of human TOR. Recognizes the ~290 kDa
Protocol- 03-0179-00
Test Point (Response)
Background
(Response)
Slope
(RE/pg/mL) S:B Ratio
# 1 143 5 230 30
# 2 140 4 227 39
# 3 131 4 210 30
#
SMC Plate-based Immunoassay Development Kit (5 plates)
Test Point (Response)
Background
(Response)
Slope
(RE/pg/mL)
S:B Ratio
# 1 143 5 230 30
# 2 140 4 227 39
# 3 131 4 210 30
#
1/4